Logo image of SCHA.OL

SCHIBSTED ASA-CL A (SCHA.OL) Stock Fundamental Analysis

OSL:SCHA - Euronext Oslo - NO0003028904 - Common Stock - Currency: NOK

314.2  +5.2 (+1.68%)

Fundamental Rating

5

Taking everything into account, SCHA scores 5 out of 10 in our fundamental rating. SCHA was compared to 57 industry peers in the Media industry. While SCHA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. While showing a medium growth rate, SCHA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SCHA was profitable.
In the past year SCHA had a positive cash flow from operations.
SCHA had positive earnings in 4 of the past 5 years.
SCHA had a positive operating cash flow in each of the past 5 years.
SCHA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCHA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

SCHA has a better Return On Assets (32.31%) than 96.49% of its industry peers.
SCHA's Return On Equity of 39.89% is amongst the best of the industry. SCHA outperforms 96.49% of its industry peers.
SCHA has a worse Return On Invested Capital (2.09%) than 70.18% of its industry peers.
SCHA had an Average Return On Invested Capital over the past 3 years of 2.06%. This is significantly below the industry average of 8.92%.
The last Return On Invested Capital (2.09%) for SCHA is above the 3 year average (2.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 32.31%
ROE 39.89%
ROIC 2.09%
ROA(3y)1.92%
ROA(5y)14.39%
ROE(3y)-1.98%
ROE(5y)16.93%
ROIC(3y)2.06%
ROIC(5y)2.64%
SCHA.OL Yearly ROA, ROE, ROICSCHA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

SCHA has a Profit Margin of 155.64%. This is amongst the best in the industry. SCHA outperforms 98.25% of its industry peers.
In the last couple of years the Profit Margin of SCHA has grown nicely.
SCHA has a Operating Margin of 12.17%. This is in the better half of the industry: SCHA outperforms 77.19% of its industry peers.
SCHA's Operating Margin has declined in the last couple of years.
SCHA's Gross Margin of 111.90% is amongst the best of the industry. SCHA outperforms 98.25% of its industry peers.
In the last couple of years the Gross Margin of SCHA has remained more or less at the same level.
Industry RankSector Rank
OM 12.17%
PM (TTM) 155.64%
GM 111.9%
OM growth 3Y-1.54%
OM growth 5Y-3.72%
PM growth 3Y-18.04%
PM growth 5Y99.1%
GM growth 3Y-1.25%
GM growth 5Y-1.05%
SCHA.OL Yearly Profit, Operating, Gross MarginsSCHA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SCHA is destroying value.
The number of shares outstanding for SCHA has been increased compared to 1 year ago.
The number of shares outstanding for SCHA has been reduced compared to 5 years ago.
SCHA has a better debt/assets ratio than last year.
SCHA.OL Yearly Shares OutstandingSCHA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SCHA.OL Yearly Total Debt VS Total AssetsSCHA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

SCHA has a debt to FCF ratio of 5.81. This is a neutral value as SCHA would need 5.81 years to pay back of all of its debts.
The Debt to FCF ratio of SCHA (5.81) is comparable to the rest of the industry.
SCHA has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
SCHA has a better Debt to Equity ratio (0.11) than 78.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 5.81
Altman-Z N/A
ROIC/WACC0.25
WACC8.31%
SCHA.OL Yearly LT Debt VS Equity VS FCFSCHA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

SCHA has a Current Ratio of 3.04. This indicates that SCHA is financially healthy and has no problem in meeting its short term obligations.
SCHA's Current ratio of 3.04 is amongst the best of the industry. SCHA outperforms 96.49% of its industry peers.
SCHA has a Quick Ratio of 3.04. This indicates that SCHA is financially healthy and has no problem in meeting its short term obligations.
SCHA has a better Quick ratio (3.04) than 96.49% of its industry peers.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 3.04
SCHA.OL Yearly Current Assets VS Current LiabilitesSCHA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

SCHA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 193.64%, which is quite impressive.
SCHA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.81% yearly.
Looking at the last year, SCHA shows a very negative growth in Revenue. The Revenue has decreased by -47.16% in the last year.
Measured over the past years, SCHA shows a very negative growth in Revenue. The Revenue has been decreasing by -15.28% on average per year.
EPS 1Y (TTM)193.64%
EPS 3Y75.21%
EPS 5Y33.81%
EPS Q2Q%1042.55%
Revenue 1Y (TTM)-47.16%
Revenue growth 3Y-17.12%
Revenue growth 5Y-15.28%
Sales Q2Q%-48.48%

3.2 Future

The Earnings Per Share is expected to decrease by -26.48% on average over the next years. This is quite bad
Based on estimates for the next years, SCHA will show a small growth in Revenue. The Revenue will grow by 4.19% on average per year.
EPS Next Y-81.01%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
EPS Next 5YN/A
Revenue Next Year-1.93%
Revenue Next 2Y3.69%
Revenue Next 3Y4.19%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SCHA.OL Yearly Revenue VS EstimatesSCHA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
SCHA.OL Yearly EPS VS EstimatesSCHA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20 -20

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.01, which indicates a correct valuation of SCHA.
The rest of the industry has a similar Price/Earnings ratio as SCHA.
When comparing the Price/Earnings ratio of SCHA to the average of the S&P500 Index (28.79), we can say SCHA is valued rather cheaply.
The Price/Forward Earnings ratio is 68.51, which means the current valuation is very expensive for SCHA.
68.42% of the companies in the same industry are cheaper than SCHA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, SCHA is valued quite expensively.
Industry RankSector Rank
PE 13.01
Fwd PE 68.51
SCHA.OL Price Earnings VS Forward Price EarningsSCHA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

71.93% of the companies in the same industry are cheaper than SCHA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SCHA is valued a bit more expensive than 75.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 110.03
EV/EBITDA 20.25
SCHA.OL Per share dataSCHA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The decent profitability rating of SCHA may justify a higher PE ratio.
A cheap valuation may be justified as SCHA's earnings are expected to decrease with -26.48% in the coming years.
PEG (NY)N/A
PEG (5Y)0.38
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.42%, SCHA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.66, SCHA has a dividend in line with its industry peers.
SCHA's Dividend Yield is comparable with the S&P500 average which is at 2.47.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

On average, the dividend of SCHA grows each year by 113.59%, which is quite nice.
Dividend Growth(5Y)113.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

SCHA pays out 157.84% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of SCHA has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP157.84%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
SCHA.OL Yearly Income VS Free CF VS DividendSCHA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B
SCHA.OL Dividend Payout.SCHA.OL Dividend Payout, showing the Payout Ratio.SCHA.OL Dividend Payout.PayoutRetained Earnings

SCHIBSTED ASA-CL A

OSL:SCHA (4/25/2025, 7:00:00 PM)

314.2

+5.2 (+1.68%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-07 2025-02-07/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners84.23%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap73.50B
Analysts70.43
Price Target357.11 (13.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend89.76
Dividend Growth(5Y)113.59%
DP157.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1016.78%
Min EPS beat(2)545.98%
Max EPS beat(2)1487.57%
EPS beat(4)2
Avg EPS beat(4)375.92%
Min EPS beat(4)-514.8%
Max EPS beat(4)1487.57%
EPS beat(8)3
Avg EPS beat(8)55.15%
EPS beat(12)3
Avg EPS beat(12)7.91%
EPS beat(16)4
Avg EPS beat(16)-1.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-2.05%
Max Revenue beat(2)1.72%
Revenue beat(4)2
Avg Revenue beat(4)-3.07%
Min Revenue beat(4)-19.17%
Max Revenue beat(4)7.24%
Revenue beat(8)4
Avg Revenue beat(8)-1.96%
Revenue beat(12)5
Avg Revenue beat(12)-1.76%
Revenue beat(16)7
Avg Revenue beat(16)-1.46%
PT rev (1m)-3.41%
PT rev (3m)-0.9%
EPS NQ rev (1m)-85.9%
EPS NQ rev (3m)-51.94%
EPS NY rev (1m)-18.45%
EPS NY rev (3m)-33.39%
Revenue NQ rev (1m)-1.79%
Revenue NQ rev (3m)-21.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.12%
Valuation
Industry RankSector Rank
PE 13.01
Fwd PE 68.51
P/S 8.83
P/FCF 110.03
P/OCF 51.04
P/B 2.26
P/tB 2.98
EV/EBITDA 20.25
EPS(TTM)24.15
EY7.69%
EPS(NY)4.59
Fwd EY1.46%
FCF(TTM)2.86
FCFY0.91%
OCF(TTM)6.16
OCFY1.96%
SpS35.59
BVpS138.87
TBVpS105.57
PEG (NY)N/A
PEG (5Y)0.38
Profitability
Industry RankSector Rank
ROA 32.31%
ROE 39.89%
ROCE 2.71%
ROIC 2.09%
ROICexc 2.45%
ROICexgc 3.24%
OM 12.17%
PM (TTM) 155.64%
GM 111.9%
FCFM 8.02%
ROA(3y)1.92%
ROA(5y)14.39%
ROE(3y)-1.98%
ROE(5y)16.93%
ROIC(3y)2.06%
ROIC(5y)2.64%
ROICexc(3y)2.28%
ROICexc(5y)2.84%
ROICexgc(3y)3.08%
ROICexgc(5y)3.81%
ROCE(3y)2.73%
ROCE(5y)3.46%
ROICexcg growth 3Y1.98%
ROICexcg growth 5Y-40.51%
ROICexc growth 3Y-1.35%
ROICexc growth 5Y-24.02%
OM growth 3Y-1.54%
OM growth 5Y-3.72%
PM growth 3Y-18.04%
PM growth 5Y99.1%
GM growth 3Y-1.25%
GM growth 5Y-1.05%
F-Score7
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 5.81
Debt/EBITDA 1.07
Cap/Depr 31.02%
Cap/Sales 9.27%
Interest Coverage 3.34
Cash Conversion 41.12%
Profit Quality 5.16%
Current Ratio 3.04
Quick Ratio 3.04
Altman-Z N/A
F-Score7
WACC8.31%
ROIC/WACC0.25
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.96%
Cap/Sales(5y)8.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)193.64%
EPS 3Y75.21%
EPS 5Y33.81%
EPS Q2Q%1042.55%
EPS Next Y-81.01%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.16%
Revenue growth 3Y-17.12%
Revenue growth 5Y-15.28%
Sales Q2Q%-48.48%
Revenue Next Year-1.93%
Revenue Next 2Y3.69%
Revenue Next 3Y4.19%
Revenue Next 5YN/A
EBIT growth 1Y-22.26%
EBIT growth 3Y-18.4%
EBIT growth 5Y-18.43%
EBIT Next Year113.35%
EBIT Next 3Y48.65%
EBIT Next 5YN/A
FCF growth 1Y1.06%
FCF growth 3Y-24.42%
FCF growth 5Y-19.17%
OCF growth 1Y-15.69%
OCF growth 3Y-16.77%
OCF growth 5Y-12.73%